Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Shifting Patient Responsibility

From the patient to the provider to the payer, healthcare is a busy operating system that everyone plays an important role in. Reflecting on his journey in healthcare and the current operating system is Nick Love, a Benefit Strategist with Brinson Benefits. Host of  Highway to Health host David Kemp sat down with Love to talk about his…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

From the patient to the provider to the payer, healthcare is a busy operating system that everyone plays an important role in. Reflecting on his journey in healthcare and the current operating system is Nick Love, a Benefit Strategist with Brinson Benefits. Host of Highway to Health host David Kemp sat down with Love to talk about his journey.

Love admittedly became interested in healthcare from an entrepreneurial and financial aspect, but over the years this has changed. “I’ve experienced healthcare in my personal life and…just how difficult it is navigating the system…that’s what I can help with and help people do…that’s what’s kept me in, is the ability to help people, to advocate for other people and show them better ways to be consumers and buyers of healthcare and healthcare services, really,” said Love.

Getting better is usually the #1 priority when you’re sick, and having someone to guide you through the process and advocate on your behalf is key. Love said, “That’s the foundation of our firm, really is to be advocates for other people. Whether you’re an employer, the buyer of healthcare for your people or you’re the end user.”

Healthcare should not be a confusing topic, but it is often an overly difficult and increasingly murky system. “Why does it cost $1,500 dollars for an MRI at one facility but $350 at another? And which one’s better? How do you decide? How do you know that?” reflected Love.

While virtual care can bring more attention to those who need it, it can also be misused. This is where patient responsibility comes in. As patients become more aware of the system and the price, patient responsibility is shifting to advocate for more transparent healthcare transactions, or opting out of professionally monitoring their health altogether. With healthcare costs continuing to rise, it falls to the patient, and people like Love, to advocate for change.

More Like This Story:

How Josh Byrd Uses Songwriting Experience to Tell the Patient Story

Educating Customers Will Be Key to Balancing Customers Expectations With Healthcare Plans

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512